| urate transport | GO:0015747 | 1 | 0.626 | |
| urogenital system development | GO:0001655 | 261 | 0.331 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.308 | |
| carnitine transmembrane transport | GO:1902603 | 3 | 0.273 | |
| cation transport | GO:0006812 | 399 | 0.253 | |
| regulation of cell motility | GO:2000145 | 236 | 0.192 | |
| amino acid betaine transport | GO:0015838 | 3 | 0.185 | |
| carnitine transport | GO:0015879 | 3 | 0.172 | |
| nephron tubule development | GO:0072080 | 84 | 0.171 | |
| renal system development | GO:0072001 | 225 | 0.165 | |
| transmembrane transport | GO:0055085 | 412 | 0.164 | Rat |
| cation transmembrane transport | GO:0098655 | 266 | 0.149 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.146 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.143 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.140 | Rat |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.125 | |
| heart morphogenesis | GO:0003007 | 178 | 0.118 | |
| cation homeostasis | GO:0055080 | 212 | 0.116 | |
| cellular homeostasis | GO:0019725 | 240 | 0.115 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.114 | |
| kidney development | GO:0001822 | 213 | 0.102 | |
| axonogenesis | GO:0007409 | 274 | 0.101 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.100 | Rat |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.100 | |
| nephron development | GO:0072006 | 109 | 0.094 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.092 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.090 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.089 | |
| organic acid transport | GO:0015849 | 101 | 0.089 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.087 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.086 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.086 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.085 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.084 | |
| regulation of ion transport | GO:0043269 | 215 | 0.081 | |
| skeletal system development | GO:0001501 | 356 | 0.081 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.081 | |
| gland development | GO:0048732 | 330 | 0.080 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.078 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.076 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.075 | |
| blood circulation | GO:0008015 | 195 | 0.075 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.073 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.073 | |
| regulation of cell migration | GO:0030334 | 219 | 0.073 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.072 | |
| spermatogenesis | GO:0007283 | 284 | 0.071 | |
| cell fate commitment | GO:0045165 | 210 | 0.068 | |
| stem cell differentiation | GO:0048863 | 268 | 0.065 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.064 | |
| renal system process | GO:0003014 | 48 | 0.064 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.063 | |
| renal tubule development | GO:0061326 | 87 | 0.063 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.063 | |
| camera type eye development | GO:0043010 | 266 | 0.062 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.061 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.061 | |
| chemotaxis | GO:0006935 | 247 | 0.060 | |
| glucose homeostasis | GO:0042593 | 128 | 0.058 | |
| modified amino acid transport | GO:0072337 | 5 | 0.057 | |
| inflammatory response | GO:0006954 | 244 | 0.057 | |
| cerebral cortex development | GO:0021987 | 86 | 0.056 | |
| tissue remodeling | GO:0048771 | 102 | 0.055 | |
| amine metabolic process | GO:0009308 | 45 | 0.054 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.054 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.053 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.053 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.053 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.053 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.052 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.052 | |
| skin development | GO:0043588 | 220 | 0.051 | |
| tumor necrosis factor production | GO:0032640 | 50 | 0.051 | |
| metanephros development | GO:0001656 | 79 | 0.051 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.051 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.050 | |
| negative regulation of serotonin secretion | GO:0014063 | 2 | 0.050 | |
| muscle contraction | GO:0006936 | 101 | 0.049 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.048 | |
| circulatory system process | GO:0003013 | 197 | 0.048 | |
| mesenchyme development | GO:0060485 | 152 | 0.048 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.047 | |
| digestive system development | GO:0055123 | 200 | 0.047 | |
| regulation of system process | GO:0044057 | 200 | 0.046 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.046 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.046 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.046 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.045 | |
| insulin secretion | GO:0030073 | 89 | 0.044 | |
| muscle tissue development | GO:0060537 | 308 | 0.044 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.044 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.044 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.044 | |
| respiratory tube development | GO:0030323 | 167 | 0.043 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.043 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.043 | |
| hormone secretion | GO:0046879 | 128 | 0.043 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.043 | |
| leukocyte migration | GO:0050900 | 124 | 0.043 | |
| ossification | GO:0001503 | 216 | 0.042 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.042 | |
| epithelium migration | GO:0090132 | 63 | 0.042 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.041 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.041 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.041 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.041 | |
| cell adhesion | GO:0007155 | 329 | 0.041 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.040 | |
| cardiac chamber development | GO:0003205 | 108 | 0.040 | |
| cytokine production | GO:0001816 | 319 | 0.040 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.040 | |
| synaptic transmission | GO:0007268 | 329 | 0.039 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.039 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.039 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.039 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.038 | |
| tissue homeostasis | GO:0001894 | 115 | 0.038 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.038 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.038 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.038 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.037 | |
| epithelial cell development | GO:0002064 | 159 | 0.037 | |
| sodium ion transport | GO:0006814 | 73 | 0.037 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.037 | |
| regulation of defense response | GO:0031347 | 233 | 0.036 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.036 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.035 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.035 | |
| cervix development | GO:0060067 | 2 | 0.035 | |
| response to peptide | GO:1901652 | 136 | 0.035 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.035 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.034 | |
| detection of chemical stimulus involved in sensory perception of taste | GO:0050912 | 3 | 0.034 | |
| stem cell development | GO:0048864 | 219 | 0.034 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.033 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.033 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.033 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.033 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.033 | |
| locomotory behavior | GO:0007626 | 195 | 0.032 | |
| calcium ion transport | GO:0006816 | 159 | 0.032 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.032 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.032 | |
| endocytosis | GO:0006897 | 168 | 0.032 | |
| digestive tract development | GO:0048565 | 190 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.031 | |
| adult behavior | GO:0030534 | 135 | 0.031 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.031 | |
| cellular phosphate ion homeostasis | GO:0030643 | 2 | 0.031 | |
| angiogenesis | GO:0001525 | 201 | 0.031 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.031 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.031 | |
| response to growth factor | GO:0070848 | 198 | 0.031 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.030 | |
| carnitine metabolic process | GO:0009437 | 7 | 0.030 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.030 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.030 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.030 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.030 | |
| amino acid betaine metabolic process | GO:0006577 | 7 | 0.030 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.029 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.029 | |
| histamine uptake | GO:0051615 | 1 | 0.029 | |
| odontogenesis | GO:0042476 | 78 | 0.029 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.029 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.029 | |
| peptide transport | GO:0015833 | 133 | 0.029 | |
| regulation of secretion | GO:0051046 | 274 | 0.029 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.028 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.028 | |
| oviduct development | GO:0060066 | 3 | 0.028 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.028 | |
| telencephalon development | GO:0021537 | 186 | 0.028 | |
| cell chemotaxis | GO:0060326 | 81 | 0.028 | |
| dephosphorylation | GO:0016311 | 129 | 0.028 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.028 | |
| protein targeting | GO:0006605 | 143 | 0.028 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.028 | |
| multicellular organism growth | GO:0035264 | 161 | 0.028 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.028 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.028 | |
| sclerotome development | GO:0061056 | 4 | 0.027 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.027 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.027 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.027 | |
| regionalization | GO:0003002 | 337 | 0.027 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.027 | |
| nephron epithelium development | GO:0072009 | 92 | 0.026 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.026 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.026 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.026 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.026 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.026 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.026 | |
| sensory perception | GO:0007600 | 245 | 0.026 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.026 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.026 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.026 | |
| heart contraction | GO:0060047 | 93 | 0.026 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.025 | |
| t cell activation | GO:0042110 | 289 | 0.025 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.025 | |
| digestion | GO:0007586 | 40 | 0.025 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.025 | |
| response to acid chemical | GO:0001101 | 111 | 0.025 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.025 | |
| amide transport | GO:0042886 | 138 | 0.025 | |
| notch signaling pathway | GO:0007219 | 71 | 0.025 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.025 | |
| monoamine transport | GO:0015844 | 33 | 0.025 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.024 | |
| defense response to other organism | GO:0098542 | 197 | 0.024 | |
| regulation of granulocyte macrophage colony stimulating factor production | GO:0032645 | 3 | 0.024 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.024 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.024 | |
| gliogenesis | GO:0042063 | 141 | 0.024 | |
| anion transport | GO:0006820 | 177 | 0.024 | Rat |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.024 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.024 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.024 | |
| lateral inhibition | GO:0046331 | 1 | 0.024 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.024 | |
| regulation of protein localization | GO:0032880 | 231 | 0.024 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.024 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.024 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.024 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.024 | |
| protein ubiquitination | GO:0016567 | 171 | 0.023 | |
| sensory system development | GO:0048880 | 3 | 0.023 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.023 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.023 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.023 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.023 | |
| developmental maturation | GO:0021700 | 193 | 0.023 | |
| kidney epithelium development | GO:0072073 | 121 | 0.023 | |
| mesoderm formation | GO:0001707 | 62 | 0.023 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.023 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.023 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.023 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.022 | |
| intracellular protein transport | GO:0006886 | 204 | 0.022 | |
| gtp metabolic process | GO:0046039 | 144 | 0.022 | |
| neural tube development | GO:0021915 | 160 | 0.022 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.022 | |
| neuron death | GO:0070997 | 154 | 0.022 | |
| mesenchyme morphogenesis | GO:0072132 | 32 | 0.022 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.022 | |
| pallium development | GO:0021543 | 120 | 0.022 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.022 | |
| male gamete generation | GO:0048232 | 285 | 0.022 | |
| tissue migration | GO:0090130 | 68 | 0.022 | |
| hippocampus development | GO:0021766 | 52 | 0.022 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.022 | |
| actin filament organization | GO:0007015 | 113 | 0.022 | |
| single organism nuclear import | GO:1902593 | 95 | 0.022 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.022 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.022 | |
| chromatin modification | GO:0016568 | 187 | 0.022 | |
| hormone metabolic process | GO:0042445 | 86 | 0.022 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.022 | |
| extracellular structure organization | GO:0043062 | 148 | 0.022 | |
| natural killer cell chemotaxis | GO:0035747 | 1 | 0.022 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.021 | |
| lung development | GO:0030324 | 164 | 0.021 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.021 | |
| placenta development | GO:0001890 | 140 | 0.021 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.021 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.021 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.021 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.021 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.021 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.021 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.020 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.020 | |
| defense response to bacterium | GO:0042742 | 119 | 0.020 | |
| mesoderm development | GO:0007498 | 100 | 0.020 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.020 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.020 | |
| endothelium development | GO:0003158 | 45 | 0.020 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.020 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.020 | |
| neuromuscular process | GO:0050905 | 99 | 0.020 | |
| t cell differentiation | GO:0030217 | 174 | 0.020 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.020 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.020 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.020 | |
| endocrine system development | GO:0035270 | 98 | 0.020 | |
| fertilization | GO:0009566 | 127 | 0.020 | |
| acid secretion | GO:0046717 | 33 | 0.020 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.020 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.020 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.019 | |
| hydrogen ion transmembrane transport | GO:1902600 | 25 | 0.019 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.019 | |
| peptide secretion | GO:0002790 | 114 | 0.019 | |
| regulation of protein transport | GO:0051223 | 163 | 0.019 | |
| cell division | GO:0051301 | 120 | 0.019 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.019 | |
| regulation of neuron death | GO:1901214 | 134 | 0.019 | |
| regulation of tube size | GO:0035150 | 57 | 0.019 | |
| pituitary gland development | GO:0021983 | 38 | 0.019 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.019 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.019 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.019 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.019 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.019 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.019 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.019 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.019 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.019 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.018 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.018 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.018 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.018 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.018 | |
| epithelial cell migration | GO:0010631 | 63 | 0.018 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.018 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.018 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.018 | |
| catecholamine transport | GO:0051937 | 21 | 0.018 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.018 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.018 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.018 | |
| segmentation | GO:0035282 | 93 | 0.018 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.018 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.018 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.017 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.017 | |
| connective tissue development | GO:0061448 | 179 | 0.017 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.017 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.017 | |
| positive regulation of gliogenesis | GO:0014015 | 27 | 0.017 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.017 | |
| epidermis development | GO:0008544 | 187 | 0.017 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.017 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.017 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.017 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.017 | |
| regulation of ossification | GO:0030278 | 112 | 0.017 | |
| myotube differentiation | GO:0014902 | 105 | 0.016 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.016 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.016 | |
| mesonephros development | GO:0001823 | 97 | 0.016 | |
| stem cell maintenance | GO:0019827 | 130 | 0.016 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.016 | |
| globus pallidus development | GO:0021759 | 2 | 0.016 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.016 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.016 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.016 | |
| chromatin organization | GO:0006325 | 206 | 0.016 | |
| renal inner medulla development | GO:0072053 | 3 | 0.016 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.016 | |
| embryonic placenta development | GO:0001892 | 98 | 0.016 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.016 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.016 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.016 | |
| toxin transport | GO:1901998 | 38 | 0.016 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.015 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.015 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.015 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.015 | |
| respiratory system development | GO:0060541 | 190 | 0.015 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.015 | |
| response to monosaccharide | GO:0034284 | 67 | 0.015 | |
| cellular divalent inorganic anion homeostasis | GO:0072501 | 3 | 0.015 | |
| diencephalon development | GO:0021536 | 63 | 0.015 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.015 | |
| nuclear transport | GO:0051169 | 139 | 0.015 | |
| amino acid transport | GO:0006865 | 61 | 0.015 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.015 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.015 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.015 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.015 | |
| heart process | GO:0003015 | 94 | 0.015 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.015 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.015 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.015 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.015 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.015 | |
| hair follicle development | GO:0001942 | 85 | 0.015 | |
| regulation of thyroid hormone generation | GO:2000609 | 4 | 0.015 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.015 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.015 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.015 | |
| primary neural tube formation | GO:0014020 | 95 | 0.015 | |
| inorganic anion transport | GO:0015698 | 43 | 0.015 | Rat |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.014 | |
| blastocyst development | GO:0001824 | 80 | 0.014 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.014 | |
| gastrulation | GO:0007369 | 116 | 0.014 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.014 | |
| myoblast differentiation | GO:0045445 | 52 | 0.014 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.014 | |
| action potential | GO:0001508 | 78 | 0.014 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.014 | |
| interleukin 8 production | GO:0032637 | 4 | 0.014 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.014 | |
| lung epithelium development | GO:0060428 | 37 | 0.014 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.014 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.014 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.014 | |
| epithelial tube formation | GO:0072175 | 130 | 0.014 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.014 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.014 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.014 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.014 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.014 | |
| ascending thin limb development | GO:0072021 | 2 | 0.014 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.014 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.013 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.013 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.013 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.013 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.013 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.013 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.013 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.013 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.013 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.013 | |
| response to nutrient levels | GO:0031667 | 109 | 0.013 | |
| response to inorganic substance | GO:0010035 | 96 | 0.013 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.013 | |
| sensory perception of pain | GO:0019233 | 47 | 0.013 | |
| thick ascending limb development | GO:0072023 | 2 | 0.013 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.013 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.013 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.013 | |
| b cell activation | GO:0042113 | 161 | 0.013 | |
| immune effector process | GO:0002252 | 321 | 0.013 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.013 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.013 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.013 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.013 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.013 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.013 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.013 | |
| lung cell differentiation | GO:0060479 | 30 | 0.013 | |
| tendon formation | GO:0035992 | 4 | 0.013 | |
| acute inflammatory response | GO:0002526 | 41 | 0.013 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.013 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.013 | |
| muscle system process | GO:0003012 | 141 | 0.013 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.013 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.013 | |
| cartilage development | GO:0051216 | 140 | 0.013 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.013 | Rat |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.013 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.013 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.013 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.012 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.012 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.012 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.012 | |
| ectoderm formation | GO:0001705 | 3 | 0.012 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.012 | |
| calcium independent cell cell adhesion via plasma membrane cell adhesion molecules | GO:0016338 | 4 | 0.012 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.012 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.012 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.012 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.012 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.012 | |
| hindbrain formation | GO:0021576 | 1 | 0.012 | |
| regulation of cell division | GO:0051302 | 76 | 0.012 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.012 | |
| detection of stimulus | GO:0051606 | 84 | 0.012 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.012 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.012 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.012 | |
| mucopolysaccharide metabolic process | GO:1903510 | 25 | 0.012 | |
| neuronal action potential | GO:0019228 | 54 | 0.012 | |
| hypothalamus development | GO:0021854 | 16 | 0.012 | |
| plasma membrane organization | GO:0007009 | 90 | 0.012 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.012 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.012 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.012 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.012 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.012 | |
| response to vitamin d | GO:0033280 | 3 | 0.012 | |
| specification of organ position | GO:0010159 | 3 | 0.012 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.012 | |
| ureteric bud development | GO:0001657 | 94 | 0.012 | |
| limbic system development | GO:0021761 | 72 | 0.012 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.012 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.012 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.012 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.012 | |
